Overview

Tranexamic Acid (TXA) in Hip Arthroscopy

Status:
Withdrawn
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
The primary goal of this study will be to determine if perioperative IV Tranexamic Acid (TXA) administration will reduce intra-operative bleeding and subsequently improve visual clarity during surgery and reduce operative traction time in patients undergoing hip arthroscopy. Additionally, this study aims to determine whether IV TXA injections will reduce post-operative pain and affect hip-specific patient-reported outcomes in patients undergoing hip arthroscopy.
Phase:
Phase 3
Details
Lead Sponsor:
Northwestern University
Treatments:
Tranexamic Acid